Home > Financial Ratios > NGL FINECHEM
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) -48.67-10.49286.35-37.36-

What is the latest Core EBITDA Growth ratio of NGL FINECHEM ?

The latest Core EBITDA Growth ratio of NGL FINECHEM is -48.67 based on Mar2023 Consolidated results.
Year Core EBITDA Growth
Mar2023-48.67
Mar2022-10.49
Mar2021286.35
Mar2020-37.36
Mar2019-

How is Core EBITDA Growth of NGL FINECHEM Trending?

Years Core EBITDA Growth % Change
Mar2023 -48.67
Negative
Mar2022 -10.49
Negative
Mar2021 286.35
Positive
Mar2020 -37.36
0
Mar2019 0 -

Other Financial Ratios of NGL FINECHEM


Compare Core EBITDA Growth ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹1,579.5 Cr -2.8% 21.2% 70.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,452.0 Cr 1.1% -6.6% 56.7% Stock Analytics
CIPLA ₹113,132.0 Cr 0.2% -4.4% 54.3% Stock Analytics
DIVIS LABORATORIES ₹106,191.0 Cr 4.8% 18.9% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,512.0 Cr 4.3% 2.6% 29.9% Stock Analytics
ZYDUS LIFESCIENCES ₹95,954.5 Cr 2.2% -4.6% 86.6% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-2.8%

21.2%

70.3%

SENSEX

1%

2.8%

23.9%


You may also like the below Video Courses